Company Filing History:
Years Active: 2004
Title: Innovations by Karen Lacourciere
Introduction
Karen Lacourciere is an accomplished inventor based in Silver Spring, MD (US). She has made significant contributions to the field of molecular biology, particularly in the detection of drug targets related to HIV. Her innovative approach has the potential to advance research in this critical area of health.
Latest Patents
Karen holds a patent for a method titled "Rapid fluorescence detection of binding to nucleic acid drug targets labelled with highly fluorescent nucleotide base analogs." This invention focuses on identifying ligands that interact with cellular processes involved in the life-cycle of HIV. The method involves modifying an oligonucleotide corresponding to a specific RNA sequence within an infected cell by substituting 2-aminopurine. This modification allows for the measurement of interactions between the oligonucleotide and the ligand via fluorescence. The technique can be utilized to discover inhibitors of binding between rev and its response element (RRE), dimerization initiation sequences, and topoisomerases and DNA.
Career Highlights
Karen is currently associated with the United States of America as represented by the Secretary of the Air Force. Her work has been instrumental in advancing the understanding of HIV interactions at the molecular level.
Collaborations
Throughout her career, Karen has collaborated with notable colleagues, including John P Marino and James T Stivers. These partnerships have contributed to the success of her research and innovations.
Conclusion
Karen Lacourciere's work exemplifies the impact of innovative thinking in the field of molecular biology. Her patent on rapid fluorescence detection represents a significant advancement in the fight against HIV. Her contributions continue to inspire future research and development in this vital area.